Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Todos Medical Ltd (TOMDF)

Todos Medical Ltd (TOMDF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TOMDF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0479 +10.23%
on 01/04/22
0.6440 -91.80%
on 01/13/22
-0.0192 (-26.67%)
since 12/21/21
3-Month
0.0320 +65.00%
on 10/25/21
0.6440 -91.80%
on 01/13/22
+0.0144 (+37.50%)
since 10/21/21
52-Week
0.0160 +230.00%
on 08/17/21
0.6440 -91.80%
on 01/13/22
-0.0092 (-14.84%)
since 01/21/21

Most Recent Stories

More News
Pepperdine University Hosts the 22nd Annual Celebrity Flag Football Challenge®, Presented by Todos Medical’s Tollovid®

In support of First Responders, Military Service Members and Boys and Girls Youth Groups MALIBU, CALIFORNIA, Jan. 19, 2022 (GLOBE NEWSWIRE) -- via...

TOMDF : 0.0497 (-11.88%)
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies

New York, NY, and Tel Aviv, ISRAEL, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0497 (-11.88%)
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022

New York, NY, and Tel Aviv, ISRAEL, Jan. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF),a comprehensive medical...

TOMDF : 0.0497 (-11.88%)
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022

“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and Tel Aviv, ISRAEL, Jan. 10, 2022 (GLOBE...

TOMDF : 0.0497 (-11.88%)
Todos Medical CEO Provides Letter to Shareholders

New York, NY, and Tel Aviv, ISRAEL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0497 (-11.88%)
Todos Medical to Present at January 5, 2022 Emerging Growth Conference

NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical...

TOMDF : 0.0497 (-11.88%)
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista

cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster shot...

TOMDF : 0.0497 (-11.88%)
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing

CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss the authorization of Pfizer’s COVID antiviral drug & Tollovir™ Phase...

TOMDF : 0.0497 (-11.88%)
Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States

§  Provista completed validation for fingerprick At-Home sample collection of blood for the cPass neutralizing antibody test New York, NY, and Tel...

TOMDF : 0.0497 (-11.88%)
Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing

Company retains iiiNTENT SAAS artificial intelligence marketing service for Tollovid® and Tollovid Daily™ 3CL protease inhibitor dietary supplement...

TOMDF : 0.0497 (-11.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0655
2nd Resistance Point 0.0620
1st Resistance Point 0.0592
Last Price 0.0497
1st Support Level 0.0529
2nd Support Level 0.0494
3rd Support Level 0.0466

See More

52-Week High 0.6440
Fibonacci 61.8% 0.4041
Fibonacci 50% 0.3300
Fibonacci 38.2% 0.2559
Last Price 0.0497
52-Week Low 0.0160

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar